Andrew Wedlake

Andrew Wedlake is a Senior Drug Discovery Data Scientist at Exscientia since October 2021, leading the Property Prediction team and focusing on the application of machine learning methods to predict potency, binding affinity, and ADME properties. Prior to this role, Andrew served as a Discovery Data Scientist at BenevolentAI from March 2020 to October 2021 and worked as a Cheminformatics Data Scientist at the University of Cambridge from March 2019 to October 2019. Andrew completed a Doctor of Philosophy in Chemistry at the University of Cambridge from 2015 to 2019 and holds a Master of Science in Natural Sciences from the same institution, earned from 2011 to 2015.